Viking Therapeutics logo
  • About
    • Management
    • Board of Directors
    • Careers
  • Pipeline
    • Overview
    • VK2735
    • VK3019
    • VK2809
    • VK0214
    • VK5211
    • Publications
  • Investors
    • Overview
    • Stock Information
      • Stock Chart
      • Historical Price Lookup
    • News & Events
      • Press Releases
      • Webcasts
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management
      • Board of Directors
      • Committee Composition
    • Shareholder Services
      • Information Request
      • E-mail Alerts
      • Investor Relations Contacts
    • Corporate Presentation
  • Contact

Investors

  • About
    • Management
    • Board of Directors
    • Careers
  • Pipeline
    • Overview
    • VK2735
    • VK3019
    • VK2809
    • VK0214
    • VK5211
    • Publications
  • Investors
    • Overview
    • Stock Information
      • Stock Chart
      • Historical Price Lookup
    • News & Events
      • Press Releases
      • Webcasts
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management
      • Board of Directors
      • Committee Composition
    • Shareholder Services
      • Information Request
      • E-mail Alerts
      • Investor Relations Contacts
    • Corporate Presentation
  • Contact

SEC Filings


NASDAQVKTX
YearTrailing 12-MonthsCalendar Year 2026Calendar Year 2025Calendar Year 2024Calendar Year 2023Calendar Year 2022Calendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2017Calendar Year 2016Calendar Year 2015Calendar Year 2014
ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Proxy & Information StatementsOther
FormDescriptionDateFormat
DEFA14AAdditional proxy soliciting materials - definitiveApr 8, 2021Open Additional proxy soliciting materials - definitive in HTML.Open Additional proxy soliciting materials - definitive in DOC file.Open Additional proxy soliciting materials - definitive in PDF file.Open Additional proxy soliciting materials - definitive in XLS file.
DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")Apr 8, 2021Open Official notification to shareholders of matters to be brought to a vote ("Proxy") in HTML.Open Official notification to shareholders of matters to be brought to a vote ("Proxy") in DOC file.Open Official notification to shareholders of matters to be brought to a vote ("Proxy") in PDF file.Open Official notification to shareholders of matters to be brought to a vote ("Proxy") in XLS file.
logo

© Viking Therapeutics 2026

All Rights Reserved.

Contact

info@vikingtherapeutics.com

9920 Pacific Heights Blvd, Suite 500
San Diego, CA 92121
858-704-4660

Follow

Legal

Terms of Use

Privacy Policy

logo
  • About
    • Management
    • Board of Directors
    • Careers
  • Pipeline
    • Overview
    • VK2735
    • VK3019
    • VK2809
    • VK0214
    • VK5211
    • Publications
  • Investors
    • Overview
    • Stock Information
      • Stock Chart
      • Historical Price Lookup
    • News & Events
      • Press Releases
      • Webcasts
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management
      • Board of Directors
      • Committee Composition
    • Shareholder Services
      • Information Request
      • E-mail Alerts
      • Investor Relations Contacts
    • Corporate Presentation
  • Contact